Loading...
Loading...
Holder clone rankings through .
Of the 13 tracked institutions holding ELVN, 4 have a 3-year clone track record — 3 of them beat the S&P. Average holder's clone alpha: +3.6pt. It's a gauge of who owns the name, not just how many.
Among the 13 tracked institutional investors we monitor, ELVN (ENLIVEN THERAPEUTICS INC) is held with a combined value of $1.18B across 27,618,428 shares. The largest holder is FMR LLC with a position worth $496.34M (0.02% of their portfolio). 3 funds opened new positions in the most recent quarter. 6 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$1.18B
Total Shares Held
27,618,428
Institutional Holders
13
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $496.34M | 0.02% | +8.0% |
| 2 | BlackRock, Inc. | $261.84M | 0.00% | +31.0% |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | $107.73M | 0.01% | -19.1% |
| 4 | STATE STREET CORP | $70.82M | 0.00% | +27.5% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $67.21M | 0.09% | +35.3% |
| 6 | CITADEL ADVISORS LLC | $57.05M | 0.03% | -39.8% |
| 7 | VANGUARD GROUP INC | $43.15M | 0.00% | +9.7% |
| 8 | BAKER BROS. ADVISORS LP | $41.49M | 0.20% | - |
| 9 | MILLENNIUM MANAGEMENT LLC | $22.63M | 0.02% | +20.0% |
| 10 | RENAISSANCE TECHNOLOGIES LLC | $7.83M | 0.01% | New |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of ELVN with a position worth $496.34M, representing 0.02% of their portfolio. In total, 13 institutional investors hold ELVN with a combined value of $1.18B.
In the most recent quarter, 3 funds opened a new position in ELVN. Additionally, 6 increased their holdings and 3 reduced their positions.
Institutional investors hold $1.18B worth of ELVN stock across 13 positions. The largest institutional holder is FMR LLC with $496.34M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ELVN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| — |
| 7.1% |
| 2026-10-27 |
| — | 15.0% | 2026-08-06 |
SEC Schedule 13D (activist) and 13G (passive) filings for ELVN. Filed when an investor acquires 5%+ ownership.
Last Close
$44.89
2026-11-18
YTD
+188.9%
65% of 52-week range